Liver and GI Flashcards

1
Q

Liver physiology in pregnancy

A

Pregnancy is associated with increased liver metabolism
Symptoms and signs of normal pregnancy can mimic GI and liver disease
- Nausea and vomiting
- Spider naevi and palmar erythema (due to high estrogen levels) can be normal

Increase: fibrinogen, ALP (2-4 fold increase, max 400 U/L)
Decreased total serum protein, albumin, GGT
Fall in upper limit of ALT/AST
No change in bilirubin

Progesterone also reduces gallbladder emptying –> predisposes to gallstone formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HELLP incidence

Lab changes

A

Affects 5-10% of PET pregnancies
Up to 1/3 of women with HELLP will not have HTN or proteinuria

LDH - Increase - can be indicative of haemolysis (as can schizocytes on peripheral smear, elevated bilirubin)
Low platelets
Mild increase ALT/AST, urate, WCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Complications of HELLP

A
Eclampsia
Maternal mortality - ~1% (pending recourse settings)
Perinatal mortality 7-60%
Placental abruption
Liver subcapsular haematoma
- Liver infarction, rupture or necrosis
Acute renal failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Recurrence of HELLP

A

Up to 25%

Risk of recurrence for any type of PET / eclampsia is 45%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Management of HELLP

A
If antenatal	
- Prompt delivery
- AN steroids for fetal lung maturity
MDT	
- ICU support
- Haematology
- General surgeon - If liver complication 
Monitor	
- Monitor and treat HTN, thrombocytopenia and coagulopathy
Vitamin K and FFP if coagulopathic
Fluid balance
Consider platelets at time of delivery
MgSO4 - if at risk of eclampsia
Steroids - some evidence for use of steroids for women who develop postnatal HELLP
Imaging	
- Consider abdomen / liver imaging if abdominal pain, shoulder tip pain, or hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Liver complications of HELLP

A

Hepatic bleeding or swelling –> liver rupture
~1% of subcapsular haematoma
Involve liver trauma surgeon
If haematoma contained, treat conservatively
Options:
- Packing
- Drainage
- Hepatic artery ligation
- Resection of affected areas
Percutaneous embolisation of hepatic arteries is reasonable 1st line therapy if haemodynamically stable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Obstetric cholestasis incidence

A

NZ / Au - 1%
- Increased risk in Indian and Pakistani women
Earlier presentation if HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Obstetric cholestasis - key points of presentation

A

Diagnosed when otherwise unexplained pruritus occurs in pregnancy and abnormal LFTs and/or raised bile acids occur in pregnant woman and both resolve after delivery

Usually presents >28/40
Bilirubin - not usually raised
Most sensitive and specific marker for the diagnosis of OC
Normal bile salt levels do not exclude the diagnosis
If persistent pruritus and normal LFTs, then repeat every 1-2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Investigations in OC

A

Exclude other causes of LFT derangement:

  • Hepatitis A, B, C
  • EBV
  • CMV
  • Liver autoimmune screen for chronic active hepatitis and primary biliary cirrhosis (e.g. anti-smooth muscle and antimitochondrial antibodies)
  • Liver ultrasound

PET screen
Glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Risk factors of OC

A
Personal Hx of OC
FHx of OC
Multiple pregnancy 
Carriage of hepatitis C
Presence of gallstones 
IVF 
Advanced maternal age 
Indian / Pakistan
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pathophysiology of OC

A

Exact cause is unknown
Thought to be secondary to the cholestatic effects of oestrogen and progesterone in genetically susceptible women –> affect the sulfation and transport of bile acids in the liver –> cholestatic effect causing regurg of bile salts into the circulation and damaging surrounding hepatocytes
Elevated bile salts –> itch, insomnia
35% have positive FHX

Geographical and season variation exists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risks to pregnancy with OC (fetal)

A

Spontaneous PTB - at most only slightly increased from the general population (4-12%)
Iatrogenic PTB
Fetal death
- The current additional risk of stillbirth in obstetric cholestasis above that of the general population has not been determined but is likely to be small (RCOG)
- Some authors suggest risk is low if <40micromol/l. Older studies suggest some risk of >40
- Only women with total bile acids >100micromol/l at any point in their pregnancy had stillbirth rates statistically significantly higher than the pooled national stillbirth rate (UTD, Lancet meta-analysis 2019). In this meta-analysis, no increase in stillbirth rate at bile acid level <100 but majority of babies were born by 39/40.
- Fetal death is usually sudden. There is no evidence of placental insufficiency

Meconium passage
NICU admission
Increased risk of RDS - appears to be associated with bile acids entering the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Risks to pregnancy with OC (Maternal)

A

Maternal - morbidity in association with intense pruritis and consequent sleep deprivation

CS rate ? Related to OC, IOL, obstetrician / patient anxiety

PPH ?

Vitamin K deficiency from malabsorbtion of fat soluble vitamins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Antenatal management of OC

A

Weekly LFTs until delivery

  • Along with general review, BP, urinalysis (to exclude other pathology)
  • Increase frequency of monitoring if deterioration in LFTs and consider other diagnoses, also check coags

Fetal monitoring - No specific method can be recommended
- Offer continuous fetal monitoring in labour
Predicting fetal outcome is difficult
- Deliver in hospital with NICU support (as increased risk of NICU admission)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Medical management of OC

A

There is no evidence that any specific treatment improves fetal or neonatal outcomes
Topical emollients - Topical aqueous cream with 1-2% menthol
- Safe, but efficacy is unknown
Antihistamines
- May provide some sedation at night

Ursodeoxycholic acid (UDCA)

  • Improves pruritus (in up to 75%) and liver function in women with OC
  • Inform women of lack of robust safety data concerning protection against stillbirth and safety to the fetus or neonate
  • Mechanism of action unclear

Rifampicin if refractory to UCDA

If prothrombin time (PT) is prolonged, 5-10mg vitamin K recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Timing of delivery in OC

A

Offer IOL from 36-40 weeks after counselling

CDHB:

  • Bile salts >100 or ALT >200 - timing of delivery to be individualised, offer for 36/40
  • Bile salts >40 or worsening LFTs - offer IOL at 38/40
  • Bile salts <40 - offer IOL at 40/40

RCT - no increased CS with IOL 37-38 weeks but increased neonatal RDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Postnatal management of OC

A

Check symptoms and LFTs normalised
- Check LFTs >10 days PN (in normal pregnancy, LFTs may increase in the first 10 days)
- Return to normal usually within 4-6 weeks
Reassurance about the lack of long-term sequelae for mother and baby
High recurrence rate (45-90%)
Contraception
- Avoid oestrogen-containing methods
- May be an increased risk of recurrent cholestasis with COCP (rare)
Increased incidence of obstetric cholestasis in family members

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

AFLP incidence

A

1 in 7,000 to 1 in 20,000 pregnancies

Newer data - maternal mortality 2%, fetal mortality 11%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

AFLP risk factors

A
Primigravida (not as marked as with PET)
Older mothers
Male fetus (3:1)
Multiple pregnancy (20% of cases)
Fetal long-chain 3-hydroxyacyl dehydrogenase deficiency
PMHx of AFLP
Low BMI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

AFLP pathogenesis

A

May be a variant of PET
Defects in fatty acid metabolism –> microvesicular fatty infiltrates of the liver –> damage to hepatocytes and liver failure
Subgroup of women who are susceptible have LCHAD deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

AFLP clinical features

A

Usually >30/40
Non-specific symptoms –> severe vomiting (60%), abdominal pain (60%), jaundice, ascites
Often co-existing mild PET (20-40%)
Abnormal LFTs - 3-10 fold increase in transaminases
Hypoglycaemia
- Unable to store or produce glucagon as liver failing
Coagulopathy due to DIC (90%)
AKI
May be lactic acidosis and raised ammonia
May develop fulminant liver failure and hepatic encephalopathy –> liver flap
Diabetes insipidus - hepatic metabolism of placenta vasopressin is impaired in AFLP –> inappropriate clearance of ADH

22
Q

Distinguishing features between AFLP and HELLP

A

Distinct features (compared to HELLP):

  • Profound hypoglycaemia (70%)
  • Marked hyperuricaemia (90%)
  • Coagulopathy (90%) in the absence of thrombocytopenia

Liver biopsy with special stains for fatty change or electron microscopy = gold standard
- Not usually practical with coagulopathy

23
Q

Management of AFLP

A

Expeditious delivery
- Regardless of fetal age as delivery initiates resolution of life-threatening disease
MDT
- ICU
- Liaison with regional liver unit
Treat coagulopathy with FFP and vitamin K (10mg iv) prior to delivery
Treat hypoglycaemia aggressively
Most women improve quickly post-delivery so management is usually conservative and support
Low threshold for antibiotics
- Significant risk of sepsis
- Gentamicin contraindicated as high risk of AKI
N-acetyl cysteine and plasmapheresis are sometimes used
Consider liver transplant
Baby should be screened for LCHAD deficiency

Recurrence risk is ~25%, more likely if heterozygous for LCHAD deficiency
Completely recovery is the norm if survives

24
Q

Autoimmune chronic active hepatitis

A

Associated with anti-smooth muscle antibodies and raised IgG levels
Usually treated with prednisolone +/- azathioprine
Continue in pregnancy

25
Primary biliary cirrhosis
Usually presents with pruritis Raised ALP and GGT Diagnosis confirmed with anti-mitochondrial antibodies Pruritis may worsen in pregnancy, UCDA can be continued or added
26
Liver cirrhosis
If severe often infertile Liver disease may decompensate during pregnancy, therefore discourage pregnancy in women with severe impairment of hepatic function Bleeding from oesophageal varices is a rise if portal HTN, especially in second and third trimester - Stabilise on beta blockers, continue throughout pregnancy
27
Liver transplant
Fertility may return to normal after transplant - Should have contraception arranged Postpone pregnancy for >18/12 to stabilise and reduce drugs post-op Usually on tacrolimus, prednisone and azathioprine - All safe in pregnancy 92% LBR Graft function and survival do not appear to be affected by pregnancy Increased risk of PET, IUGR, PTB, GDM
28
Gallbladder disease in pregnancy
1/3 of women with gallstones become symptomatic when pregnancy Oestrogen ---> increased cholesterol production Pregnancy improves gallbladder contractility --> forms sludge and gallstones Gallstones are more common in multip Acute cholecystitis occurs in 0.1% of pregnancies ``` Management - As for non-pregnancy - Conservative management - NBM, NG, IVF, antibiotics, analgesia (resolution in 3/4) - Surgery best done in second trimester ERCP - risk of pancreatitis ```
29
Pathophysiology of HG
Unknown, likely multifactorial Primarily thought to be a/w rising levels of hCG - Conditions with higher levels of hCG a/w increased severity of NVP - Also HCG peaks in the first trimester when HG is normally seen - However high HCG levels are not consistently a/w n/v Elevated serum concentrations of oestrogen and progesterone - Relax smooth muscle --> slow GI transit time, may alter gastric emptying - However these levels peak in third trimester when NVP or HG has usually resolved H. pylori may play a role in some women - H. pylori infection a/w increased likelihood of HG during pregnancy Genetic factors - increased risk of developing HG among relatives of women previously affected
30
Incidence of HG
SOMANZ – any nausea or vomiting 69% 1.1% Typically starts between 4th and 7th week Peaks ~9/40 Resolves by 20/40 in 90%
31
Nausea and vomiting of pregnancy vs. HG
Nausea and vomiting of pregnancy (NVP) - Diagnose when onset of symptoms (nausea, vomiting, dry retching) in the first trimester and other causes of n/v excluded ``` Hyperemesis gravidarum (HG) - Nausea and/or vomiting caused by pregnancy leading to significant reduction of oral intake and weight loss of >5% compared with pre-pregnancy, with or without dehydration and/or electrolyte abnormalities ```
32
Obesity in pregnancy
~50% of women who become pregnant are either overweight or obese BMI >30 pre-pregnancy or at booking visit
33
Risks of obesity | - antenatal
``` Miscarriage GDM Fetal congenital abnormalities Stillbirth PET - If BMI >35 Thromboembolism - Risk of PE > DVT Abnormalities in fetal growth Obstructive sleep apnoea Preterm birth Maternal death ```
34
Risks of obesity | - intrapartum
``` IOL, prolonged labour and failure to progress Rate of instrumental delivery Failed instrumental delivery Shoulder dystocia Caesarean section - BMI >40 = 52% of CS Difficulties with fetal heart rate monitoring PPH Peripartum death ```
35
Risks of obesity | - anaesthetic
Difficulties with labour analgesia - Correct siting within the epidural space - Increased risk of dislodgement Use of GA Difficultly maintaining an adequate airway, failed intubation Increased risk of need for ICU care post-op Difficult IV access
36
Risks of obesity | - post-partum
Delayed wound healing and infection Thromboembolic disease Greater likelihood of needing support with breastfeeding establishment and continuation Postnatal depression - Up to 40% Long term neonatal consequences - Neonatal body composition - Infant weight gain - Obesity
37
Guidelines on weight gain during pregnancy
Normal weight - 11.5 to 16kg Obese (includes all classes) - 5 to 9.1kg Losing weight during pregnancy is not recommended - Increased risk of low birth weight baby Low gestational weight gain is associated with: - PTB - Increased risk of SGA
38
Obesity | - Prepregnancy care
Discuss impact of obesity on fertility and pregnancy outcomes Medications or surgery for weight management are not recommended around the time of conception High dose (5mg) folate is recommend if BMI >30 Address psychosocial concerns Offer contraception to allow time for weight optimisation Weight loss between pregnancies: - Reduces the risk of: stillbirth, hypertensive complications, fetal macrosomia - Increases the chances of successful VBAC
39
Obesity antenatal care
MDT Nutritional supplementation: - 5mg folic acid and 150mcg iodine - Obese women are at increased risk of iron and vitamin D deficiency Flu vaccination - increased risk of major maternal morbidity with influenza during pregnancy At subsequent follow up appointments check BP (with correct size cuff) and urinalysis Offer early OGTT, with repeat at 28/40 if the early test was normal Anaesthetic assessment Consider aspirin to lower risk of PET from 12/40 FHx PET, multiple pregnancy Consider VTE risk Ultrasound - Anatomy scan less accurate (fat --> scatter effect) - BMI>35 should have serial USS
40
Obesity | - intrapartum
Check guidelines for local unit - Ensure appropriate equipment available Less likely to have a successful VBAC - Operative and anaesthetic risks of emergency CS are higher Timing of birth - No universal consensus - Observational data comparing outcomes before and after a protocol of delivery by 40/40 found a significant reduction in the risk of CS for obese women IV line on admission to labour ward May need to confirm presentation with USS FSE for monitoring Active management 3rd stage Increased dose of IV antibiotics for CS (e.g. 3g cefazolin) Awareness of increased risk of shoulder dystocia and PPH Operating theatre staff need to be altered regarding increased weight (usually >120kg)
41
Obesity - postpartum management
BMI >40 --> 50% wound infection Breastfeeding support Consider VTE prophylaxis Weight management postpartum Screen for post-natal depression Consider appropriate contraception
42
Previous bariatric surgery
Should be on lifelong vitamin supplementation Referral to dietician, especially if malabsorptive surgery - may require additional supplementation during pregnancy - vitamin B12, iron, folate, vitamin D, calcium Avoid pregnancy for 12-24 months after surgery and during the initial weight loss phase Require closer monitoring of their nutritional status and fetal growth Current evidence suggests a positive outcome in reduction of maternal risks during pregnancy, such as GDM, but with an increase risk of FGR and stillbirth Can't have OGTT due to dumping syndrome - HbA1c - BSLs for 1 week
43
Food safety in pregnancy
``` TOXOPLASMOSIS Wash hands after handing raw meet Cook meet well Do not empty cat's litter tray Wash hands after touching animals ``` LISTERIA Wash, cook, cover and chill all food Do not eat leftovers - Listeria can grow at low temp including fridge Avoid high risk foods - Soft and semi soft pasteurized cheese - Raw milk cheeses and yoghurts - Cold chicken and other processed meets - Prepared salads - Raw seafood - Raw eggs - Hummus and tahini
44
Clinical assessment | of HG
Typically starts between 4th and 7th week Peaks ~9/40 Resolves by 20/40 in 90% Typically get hyponatraemia, hypokalaemia, low serum urea, hypochloraemia, hypomagnesaemia, metabolic hypochloraemic alkalosis If severe, metabolic acidaemia may develop Measure TFTs in women with HG or NVP refractory to treatment, or those with Sx of thyrotoxicosis - If TSH
45
Maternal complications of HG
Wernicke's encephalopathy -Due to vitamin B1 (thiamine) deficiency - Potentially fatal - can be precipitated by IV dextrose Hyponatraemia - Both severe hyponatraemia and rapid reversal can --> central pontine demyelination Pyridoxine (vitamin B6) deficiency - Causes anaemia and peripheral neuropathy ``` Acute kidney injury Oesophageal rupture Rhabdomyolysis Mallory-Weiss tears Malnutrition PTSD Thrombosis ```
46
Basic stuff for HG
``` MDT IVF and fluid balance Thrombo-prophylaxis Vitamin supplementation - thiamine 100mg po OD - folic acid 5mg - Iodine 150mcg - pyridoxine ``` Acid suppression - omeprazole Psychosocial support Manage/prevent constipation
47
Anti-emetics | for HG
1st Antihistamines (H1 receptor antagonists) - Cyclizine, Promethazine - decreasing stimulation of the vomiting centre Side effects: sedation, anti-cholinergic effects Prochlorperazine - Central and peripheral dopamine antagonists - Chance of extrapyramidal side effects, oculogyric crises 2nd Metoclopramide - Dopamine and serotonin receptor antagonist - Equal to ondansetron for nausea, but less effective for vomiting - Chance of extrapyramidal side effects Ondansetron - Serotonin receptor antagonists - Potentially a/w cleft palate, cardiac defects 3rd Steroids - Cochrane 2016 - no difference in days of hospital admission compared to placebo, but there was a decreased admission rate
48
Complementary therapies for HG
Ginger ? Improves nausea but not vomiting - Ginger superior to placebo but less effective than metoclopramide Acupressure and acupuncture - Safe in pregnancy - Acupressure may improve NVP - Cochrane found no overall reduction in symptoms ``` Vitamin B6 (pyridoxine) - May improve nausea but not vomiting ```
49
Predictors of pregnancy outcome
Disease activity prior to conception - Remission >3/12 preconception --> good prognosis Hx of disease activity in previous pregnancy Crohn's tend to remit in pregnancy UC more likely to flare in pregnancy - In postpartum period flare is six times more common
50
Management of IBD in pregnancy
Encourage to conceive when in remission Mycophenolate and methotrexate should be stopped/switched 3 months before trying to conceive. Sulphalazine (5mg folic acid) and Mesalalazine safe to use throughout pregnancy and breastfeeding. Azathioprine safe in pregnancy. anti-TNF agents i.e. infliximab have growing evidence of safety - Ideally stop in third trimester so baby can clear the drug prior to delivery - Babies should not have live vaccines until 6 months of age if mother on infliximab Correct any nutritional deficiencies due to malabsorption If symptoms deteriorate: - FBC, stool culture, CRP, flexible sigmoidoscopy - For flares of colonic disease use corticosteroid enemas or oral prednisone. Regular growth scans